Anthropic details early drug development work with six partners and says it has acquired Mithril, a one-person company working on muscular dystrophy (Anthropic)

Anthropic has detailed its early drug development work, collaborating with six partners to accelerate the process. The company also announced the acquisition of Mithril, a one-person company focused on muscular dystrophy research. This move highlights Anthropic's commitment to leveraging AI for drug development, exploring applications beyond initial molecule design to speed up various stages of the process.